Composition:- Amoxycillin 500mg + Potassium Clavulanate 125 mg + Lactic Acid Bacillus 60 million spores. Description:- RUNMOX-625 is a broad-spectrum antibiotic formulation combining Amoxycillin (a penicillin-type antibiotic) with Potassium Clavulanate (a beta-lactamase inhibitor) and Lactic Acid Bacillus (a probiotic). The combination enhances antibacterial activity against a wide range of infections while supporting gut health during antibiotic therapy. *Amoxycillin: - Kills or inhibits the growth of susceptible bacteria. *Potassium Clavulanate:- Protects Amoxycillin from bacterial resistance by inhibiting beta-lactamase enzymes. *Lactic Acid Bacillus:- Helps maintain intestinal flora balance, reducing the risk of antibiotic-associated diarrhea. Uses:- *Respiratory tract infections (e.g., sinusitis, bronchitis, pneumonia) *Ear, nose, and throat infections *Urinary tract infections *Skin and soft tissue infections *Dental infections *Bone and joint infections Warning & Precautions:- *Not recommended for patients with known allergies to penicillin or cephalosporin antibiotics. *Pregnant or breastfeeding women should consult their doctor before use. *Complete the full prescribed course even if symptoms improve. *Keep out of reach of children. Storage:- Store in a cool, dry place, away from direct sunlight and moisture. Conclusion:- RUNMOX-625 Tablets offer an effective triple-action approach to treating bacterial infections by combining the power of Amoxycillin with the protective action of Potassium Clavulanate and the gut-friendly benefits of Lactic Acid Bacillus. This combination not only fights a wide range of infections but also helps maintain digestive health during treatment. When taken as prescribed by a qualified healthcare professional, RUNMOX-625 provides a reliable and well-balanced solution for fast recovery and overall patient well-being.